
US antibody development firm Immune Pharmaceuticals has appointed Gad Berdugo (pictured) as its executive VP and chief financial officer, and …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

